Timeline’s Mitopure® technology is launching globally

Levallois-Perret, France, February 13th, 2026 – Lancôme is asserting its position as the leader of the longevity scientific territory by placing longevity science at the core of its innovation strategy. By orchestrating strategic collaborations with the world’s most cutting-edge biotech firms, the brand is redefining industry standards and championing a proactive, scientific vision of beauty that moves beyond the pursuit of looking younger toward fostering biological skin’s vitality. Today, Lancôme pioneers a new era of longevity in beauty through its partnership with Swiss longevity biotech Timeline®.

Lancôme’s Partnership with Timeline®: A Breakthrough in Cellular Energy

In 2024, the L’Oréal group became the first player to position beauty at the heart of the global longevity conversation by investing in Timeline®, a Swiss biotech pioneering longevity science. Today, Lancôme brings this partnership to the forefront of the consumer market. This collaboration focuses on the mastery of Mitopure®, a proprietary molecule backed by over $50 Million in R&D and 15 years of research. Mitopure® is a highly pure form of Urolithin A, a postbiotic clinically proven to re-energize mitochondria— the powerhouses of the cell—through a cellular renewal process known as mitophagy. This partnership will set the stage for a new Lancôme skincare range combining Mitopure® with the brand’s proprietary compounds to deliver clinically proven longevity benefits on the skin. Each product is designed to act on the skin's visible biological age, marking Mitopure®’s first deployment at global scale through a major beauty brand.

“For Lancôme, longevity is a frontier of radical progress, not a matter of appearance. We are defining a new scientific era where beauty is proactive, decoding the core biological mechanisms of skin aging.

By orchestrating meaningful partnerships with the world’s most advanced biotech innovators - like Timeline and its Mitopure® molecule - we are accelerating our mission to pioneer high-performance solutions. Our goal is to shift the conversation on aging, using cutting-edge science to restore cellular vitality and offer women a new perspective on their own skin’s trajectory.”Vania Lacascade, Global Brand President of Lancôme.

“Collaborating with Lancôme marks an exciting new chapter for Timeline®, furthering our core belief in taking a multidimensional approach to redefining how we age. This partnership presents a remarkable opportunity to democratize our longevity molecule, Mitopure®, making its advanced skin benefits more widely accessible than ever.” — Chris Rinsch, co-founder and President of Timeline®.

A Bold Ambition: Leading the Territory of Skin Longevity for Lancôme

Skin longevity represents a major scientific breakthrough opening a new societal paradigm. It is no longer about masking the signs of time but decoding the fundamental biological mechanisms to preserve and restore skin healthspan. This leadership carries a responsibility: to empower consumers with knowledge and to set new standards for the category through an inclusive, optimistic vision of aging.

A Rapidly Expanding Longevity Ecosystem

The arrival of Timeline® into our Longevity Integrative Science™ ecosystem completes a progressive strategy already set in motion by Lancôme through two additional technological pillars:

Product Innovation (Absolue Longevity)

In 2025, Lancôme introduced the Absolue Longevity The Soft Cream, powered by patent pending Absolue PDRN™. Known to augment cell longevity metabolism, it adds to Lancôme’s Absolue Longevity The Soft Cream demonstrated ability to reverse visible signs of aging layer by layer.

Precision Beauty Tech (Cell BioPrint™)

Through a partnership with the Korean startup NanoEnTek, Lancôme developed a first-of-its-kind "lab-on-chip" skin analysis solution. Utilizing proteomics and microfluidics to analyze skin surface protein biomarkers, Cell BioPrint™ determines biological age of the skin surface and models future skin beauty longevity trajectories. This enables a shift from reactive correction to proactive, data-driven care.

Toward a New Paradigm of Beauty

By combining cutting-edge analysis, breakthrough active ingredients, and decoding deep cellular processes, Lancôme is not just launching products—it is building a science based and data-driven holistic approach for longevity in beauty.

The new Lancôme longevity skincare range, Mitopure® by Timeline®, will be revealed at the annual American Academy of Dermatology (AAD) convention in Denver, Colorado, from March 27th to 29th, 2026.

About Timeline®

Timeline (parent company Amazentis) is a pioneering Swiss health science company committed to revolutionizing the longevity industry with its groundbreaking, clinically proven, proprietary ingredient Mitopure®. Offering a comprehensive approach to cellular health, Timeline incorporates the benefits of Mitopure inside its next-generation nutritional supplements and topical skin health products. With more than a decade of expertise in aging science research, Timeline seeks to push the boundaries of human healthspan, contributing to a future where everyone can live longer, healthier lives. The company is backed by over 15 years of research by distinguished scientists, multiple clinical studies, and over 50 global patents. Nestlé Health Science and L’Oréal are investors in the company.

Mitopure Firming Serum

4.8 · 1458 reviews

Award-winning bioactive formula for renewal

Buy now